Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis

NCT00840359 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00840359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00840359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis
Lead sponsor
Hadassah Medical Organization
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2009
Completion date
December 31, 2012
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous leishmaniasis